|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Naftopidil ,a novel α1-adrenoceptor antagonist , displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human α1-adrenoceptors 显示文摘 | Takei R Ikegaki I Shibata K | 1999 | Jpn J Pharmacol1999，79，8： | 1 |
| 2 | Effects of epalrestat,analdose reductase inhibitor, on diabetic peripheral neu- ropathy in patients with type 2 diabetes,in relation to suppression of N-carboxymethyl lysine显示文摘 | Kawai T Takei I Tokui M | | J Diabetes Com- plications0，24，6： | 1 |
| 3 | Naftopidil,a novel alpha1-adrenoceptor antagnist,displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors显示文摘 | Takei R Ikegaki I Shibata K | 1999 | J Pharmacol1999，79，： | 1 |
| 4 | Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors 显示文摘 | Ikegaki I Shibata K | 1999 | Jpn J Pharmacol1999，79，： | 1 |
| 5 | Secretion of GIP in responders to acarbose in obese Type 2 (NIDDM) patients显示文摘 | TAKEI I MIYAMOTO K FUNAE O | 2001 | Diabetes Complications2001，15，5： | 1 |
| 6 | Molecular basis for tissue expansion : clinical implications for the surgeon 显示文摘 | Takei T Mills I Arai K | 1998 | Plast Reconstr Surg1998，102，1： | 1 |
| 7 | MSA C is the predominant clinical phenotype of MSA in Japan:analysis of 142 patients with probable MSA显示文摘 | Yabe I Soma H Takei A | 2006 | J Neurol Sci2006，249，2： | 1 |
| 8 | Future therapy of diabetes mellitus 显示文摘 | Takei I Kasatani T | 2004 | Biomed Pharmacother2004，58，10： | 1 |
| 9 | Molecular basis for tissue expansion:Clinical implications for the surgeon显示文摘 | TAKEI T MILLS I ARAI K | 1998 | Plast Reconstr Surg1998，102，1： | 1 |
| 10 | Endothelin 1 is involved in hepatic sinusoidal vasoconstriction after ischemia and reperfusion显示文摘 | Marzi I Takei Y R u ker M | 1994 | Transpl Int1994，7，1： | 1 |
| 11 | Reaction behavior of LiFePO4 as a cathode material for rechargeable lithium batteries显示文摘 | Takahashi M Tobishima S I Takei K | 2002 | Solid State Ionics2002，148，： | 1 |
| 12 | Reaction behavior of LiFePO4 as a cathode material for rechargeable lithium batteries 显示文摘 | TA~M~IASHI M TOBISHIMA S I TAKEI K SAKURAI Y | 2002 | Solid State Ionics2002，148，： | 1 |
| 13 | Effects of epalrestat,an al-dose reductase inhibitor,on diabetic peripheral neuropathy in patients with type2diabetes,in relation to suppression of N(?)-carboxymethyl lysine显示文摘 | Kawai T Takei I Tokui M | 2010 | J Diabetes Complications2010，24，6： | 1 |
| 14 | Retrospective analysis of hemodialyed diabetic patients in Japan显示文摘 | Takei I Yamauchi A Nakamoto S | 1995 | Diabetes Res Clin Pract1995，，： | 1 |
| 15 | 显示文摘 | Meguro S Takei I Murata M | 2001 | Atherosclerosis2001，156，1： | 1 |
| 16 | Ruthenium-catalysed asymmetric hydrosilylation of ketoximes using chiral oxazolinylferrocenylphosphines显示文摘 | TAKEI I NISHIBAYASHI Y ISHII Y | 2001 | Chem Commun2001，，： | 1 |
| 17 | Matrix metal oproteinases and tissue inhibitors of metal oproteinases in joint fluid of the patients with loose artificial hip joints显示文摘 | Takei I Takagi M Santavirta S | | 0，，03： | 1 |
| 18 | Associations between multiple system atrophy and polymorphisms of SLC1A4, SQSTM1, and EIF4EBP1 genes显示文摘 | Soma H Yabe I Takei A | 2008 | Mov Disord2008，23，8： | 1 |
| 19 | Molecular basis for tissue expansion : clinical implications for the surgeon 显示文摘 | Takei T Mills I Arai K | 1998 | Plast Reconstr Surg1998，102，1： | 1 |
| 20 | Naftopidil, a novel alphal-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alphal-adrenoceptors 显示文摘 | Takei R Ikegaki I Shibata K | 1999 | Jpn J Pharmacol1999，79，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员